Scientist, Cancer Immunology Discovery at Bristol-Myers Squibb

Winter Garden, Florida, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, OncologyIndustries

Requirements

Bachelor’s Degree with 5+ years of academic and/or industry experience, or Master’s Degree with 3+ years of academic and/or industry experience, or Ph.D. or equivalent advanced degree in the Life Sciences (no experience necessary)
Extensive expertise and a proven track record in cancer immunology or immunology research, with industry experience in oncology drug discovery; alternatively, a Ph.D. with a strong publication record in top-tier peer-reviewed journals (preferred)
Strong understanding of T cell biology, vascular, myeloid, and stromal biology (preferred)
Experience in the design, development, and optimization of high-throughput cell-based assays for TCE activity and multispecific biologics (preferred)
Proficient in the use of expression modulation techniques (preferred)
Excellent communication and interpersonal skills

Responsibilities

Designs and executes experiments independently, troubleshoots as needed, interprets and discusses data, with accurate, timely and detailed record-keeping
Performs laboratory work related but not limited to tissue culture, multi-parametric flow cytometry, western blot, immune cell culture using activation/expansion/exhaustion assays, proliferation and tumor killing assays, 2D/3D co-culture activity assays, ELISA, Luminex, processing of DNA/RNA/protein
Accurate and detailed record-keeping
Presents data in project meetings and department meetings
Collaborates with rest of biology team members as well as other functional area leads e.g. protein purification, in vivo pharmacology, DMPK, informatics

Skills

Cancer Immunology

Immuno-oncology

Drug Discovery

In Vitro Models

In Vivo Models

Ex Vivo Models

Target Identification

Target Validation

Biomarker Development

Translational Medicine

Cell Therapy

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free